WA
Schedule 13G filing
WASATCH ADVISORS LP disclosed a 11% stake in Journey Medical Corp (DERM)
WASATCH ADVISORS LP reported owning 11% of Journey Medical Corp (DERM) (2,449,253 shares) in a Schedule 13G filed Oct 9, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.